Skip to Main Content

Instil Bio, Inc. Common Stock

TIL Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of TIL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
TIL Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
TIL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
TIL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by TIL's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

TIL Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
TIL Income Statement
TIL Balance Sheet
TIL Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Receptors providing targeted costimulation for adoptive cell therapy Jan. 07, 2025
  • Patent Title: Aseptic tissue processing method, kit and device Dec. 24, 2024
  • Patent Title: Cells expressing recombinant growth factor receptors Oct. 15, 2024
  • Patent Title: Receptors providing targeted costimulation for adoptive cell therapy Apr. 02, 2024
  • Patent Title: Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof Sep. 26, 2023
  • Patent Title: Chimeric molecules providing targeted costimulation for adoptive cell therapy Jul. 11, 2023
  • Patent Title: Aseptic tissue processing method, kit and device Apr. 04, 2023
  • Patent Title: Aseptic tissue processing method, kit and device Apr. 04, 2023
  • Patent Title: Cells expressing recombinant growth factor receptors Dec. 20, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
TIL News

Recent insights relating to TIL

CNBC Recommendations

Recent picks made for TIL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TIL

TIL Analyst Ratings

TIL Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
TIL Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $TIL stock a Buy, Sell, or Hold?

  • What is the price target for $TIL stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

TIL Top Shareholders
Shareholder
Shares Held
TIL Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $TIL stock?

  • Who owns the most shares of $TIL stock?

  • What funds own $TIL stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

TIL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view TIL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top